经口内镜下肌切开术治疗既往接受过Heller肌切开术的贲门失弛缓症患者:系统评价与荟萃分析
本系统评价与荟萃分析纳入9项研究共272例既往接受过Heller肌切开术的贲门失弛缓症患者,评估经口内镜下肌切开术(POEM)的疗效与安全性。POEM成功实施率为99.3%,临床成功率为90.0%(95%CI 83.1%-96.8%),Eckardt评分、下食管括约肌压力和整合松弛压均显著降低。术后症状性反流、食管炎和异常pH监测的合并发生率分别为36.9%、33.0%和47.8%。作者认为POEM是安全有效的治疗选择,但需前瞻性对照研究长期随访证实。
要点
- POEM在既往Heller肌切开术患者中成功实施率为99.3%(270/272)。
- 临床成功率(Eckardt评分≤3)为90.0%(95%CI 83.1%-96.8%)。
- 术后症状性反流、食管炎和异常pH监测发生率分别为36.9%、33.0%和47.8%。
核心结论
- POEM是既往接受过Heller肌切开术的贲门失弛缓症患者安全有效的治疗方法。
- 需要前瞻性、对照、长期随访的研究数据来证实这些发现。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、Embase和Cochrane Library截至2020年1月31日的文献。
- 纳入评估既往Heller肌切开术患者接受POEM结局的研究,共纳入9项研究、272例贲门失弛缓症患者。
- 主要结局为临床成功率(定义为POEM后Eckardt评分≤3)、Eckardt评分平均变化、下食管括约肌压力和整合松弛压(IRP);次要结局为操作相关不良事件(AEs)和术后胃食管反流病(GERD)发生率。
主要发现
- POEM在270例(99.3%)既往Heller肌切开术患者中成功实施。
- 临床成功率为90.0%(95%CI 83.1%-96.8%)。
- Eckardt评分显著降低5.14(95%CI 4.19-6.09),下食管括约肌压力显著降低12.01 mmHg(95%CI 6.74-17.27),IRP显著降低10.02 mmHg(95%CI 4.95-15.09)。
- 术后症状性反流、食管炎和异常pH监测的合并发生率分别为36.9%(95%CI 20.7%-53.1%)、33.0%(95%CI 9.6%-56.4%)和47.8%(95%CI 33.4%-62.2%)。
- 所有结局指标均检测到显著异质性;大多数不良事件为自限性或经保守处理。
关键数值与推荐
- 临床成功定义为POEM后Eckardt评分≤3。
- 主要结局指标包括临床成功率、Eckardt评分平均变化、下食管括约肌压力和IRP。
- 次要结局指标为操作相关不良事件和术后GERD发生率。
临床怎么用
- 原文未据此给出推荐。
局限性
- 所有结局指标均存在显著异质性。
- 需要前瞻性、对照、长期随访的研究数据来证实这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Heller myotomy (HM) is considered the standard surgical treatment for patients with achalasia. However, approximately 10% to 20% of patients with achalasia have persistent or recurrent symptoms after HM that require further therapy. Several studies have reported the outcomes of peroral endoscopic myotomy (POEM) in these patients. We performed a systematic review and meta-analysis to evaluate the efficacy and safety of POEM in patients with achalasia with previous HM. METHODS: An electronic literature search of PubMed, Embase, and the Cochrane Library was conducted up to January 31, 2020. Studies evaluating the outcomes of POEM in patients with achalasia with previous HM were eligible for inclusion. The primary outcomes were the pooled rates of clinical success (defined as post-POEM Eckardt score ≤3), mean change in Eckardt score, lower esophageal sphincter pressure, and integrated relaxation pressure (IRP). The secondary outcomes were procedure-related adverse events (AEs) and incidence of postoperative GERD. RESULTS: A total of 9 studies involving 272 patients with achalasia were recruited in this review. POEM was successfully performed in 270 (99.3%) patients after previous HM. Clinical success was achieved in 90.0% (95% confidence interval [CI], 83.1%-96.8%) of patients. Eckardt score, lower esophageal sphincter pressure, and IRP were significantly lowered by 5.14 (95% CI, 4.19-6.09), 12.01 mm Hg (95% CI, 6.74-17.27), and 10.02 mm Hg (95% CI, 4.95-15.09), respectively. The pooled rates of postoperative symptomatic reflux, esophagitis, and abnormal pH monitoring were 36.9% (95% CI, 20.7%-53.1%), 33.0% (95% CI, 9.6%-56.4%), and 47.8% (95% CI, 33.4%-62.2%), respectively. Substantial heterogeneity was detected across all outcome measurements. Most of the AEs were self-limiting or managed conservatively. CONCLUSIONS: POEM is a safe and effective treatment for patients with achalasia with previous HM. Further data from prospective, controlled studies with long-term follow-up are needed to confirm these findings.
引用
- Huang Z, Cui Y, Li Y, et al. Peroral endoscopic myotomy for patients with achalasia with previous Heller myotomy: a systematic review and meta-analysis. Gastrointest Endosc. 2020. PMID: 32522483. doi:10.1016/j.gie.2020.05.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。